Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

545 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial.
Mercier JC, Hummler H, Durrmeyer X, Sanchez-Luna M, Carnielli V, Field D, Greenough A, Van Overmeire B, Jonsson B, Hallman M, Baldassarre J; EUNO Study Group. Mercier JC, et al. Among authors: hallman m. Lancet. 2010 Jul 31;376(9738):346-54. doi: 10.1016/S0140-6736(10)60664-2. Epub 2010 Jul 23. Lancet. 2010. PMID: 20655106 Clinical Trial.
Inhaled nitric oxide (iNO) for preventing prematurity-related bronchopulmonary dysplasia (BPD): 7-year follow-up of the European Union Nitric Oxide (EUNO) trial.
Greenough A, Decobert F, Field D, Hallman M, Hummler HD, Jonsson B, Sánchez Luna M, Van Overmeire B, Carnielli VP, Potenziano JL, Mercier JC. Greenough A, et al. Among authors: hallman m. J Perinat Med. 2020 Sep 7;49(1):104-110. doi: 10.1515/jpm-2020-0164. J Perinat Med. 2020. PMID: 32892178 Free article. Clinical Trial.
Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infants.
Durrmeyer X, Hummler H, Sanchez-Luna M, Carnielli VP, Field D, Greenough A, Van Overmeire B, Jonsson B, Hallman M, Mercier JC, Marlow N, Johnson S, Baldassarre J; European Union Nitric Oxide Study Group. Durrmeyer X, et al. Among authors: hallman m. Pediatrics. 2013 Sep;132(3):e695-703. doi: 10.1542/peds.2013-0007. Epub 2013 Aug 12. Pediatrics. 2013. PMID: 23940237 Clinical Trial.
Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.
Bassler D, Plavka R, Shinwell ES, Hallman M, Jarreau PH, Carnielli V, Van den Anker JN, Meisner C, Engel C, Schwab M, Halliday HL, Poets CF; NEUROSIS Trial Group. Bassler D, et al. Among authors: hallman m. N Engl J Med. 2015 Oct 15;373(16):1497-506. doi: 10.1056/NEJMoa1501917. N Engl J Med. 2015. PMID: 26465983 Free article. Clinical Trial.
Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia.
Bassler D, Shinwell ES, Hallman M, Jarreau PH, Plavka R, Carnielli V, Meisner C, Engel C, Koch A, Kreutzer K, van den Anker JN, Schwab M, Halliday HL, Poets CF; Neonatal European Study of Inhaled Steroids Trial Group. Bassler D, et al. Among authors: hallman m. N Engl J Med. 2018 Jan 11;378(2):148-157. doi: 10.1056/NEJMoa1708831. N Engl J Med. 2018. PMID: 29320647 Free article. Clinical Trial.
Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia.
Hadchouel A, Durrmeyer X, Bouzigon E, Incitti R, Huusko J, Jarreau PH, Lenclen R, Demenais F, Franco-Montoya ML, Layouni I, Patkai J, Bourbon J, Hallman M, Danan C, Delacourt C. Hadchouel A, et al. Among authors: hallman m. Am J Respir Crit Care Med. 2011 Nov 15;184(10):1164-70. doi: 10.1164/rccm.201103-0548OC. Epub 2011 Aug 11. Am J Respir Crit Care Med. 2011. PMID: 21836138 Free PMC article.
[EuroNeoStat: a European information system on the outcomes of care for very-low-birth-weight infants (< 1500 g)].
Valls-I-Soler A, Carnielli V, Claris O, de la Cruz Bértolo J, Halliday HL, Hallman M, Hummler H, Weindling M; Scientific Steering Committee von EuroNeoStat (siehe Anhang). Valls-I-Soler A, et al. Among authors: hallman m. Z Geburtshilfe Neonatol. 2008 Jun;212(3):116-8. doi: 10.1055/s-2008-1076802. Z Geburtshilfe Neonatol. 2008. PMID: 18709632 German.
545 results